Cullinan Therapeutics, Inc. · NASDAQ:CGEM
Michaelson Jennifer sold 8,000 Cullinan Therapeutics, Inc. shares (Form 4)
Traded May 5, 2026 · Filed May 6, 2026
On May 5, 2026, Michaelson Jennifer (Chief Scientific Officer) sold 8,000 Cullinan Therapeutics, Inc. shares at an average US$14.62 for US$117K under a trading plan, leaving 166,844 shares. Filed May 6, 2026 (Form 4).
- Sold
- 8,000 shares
- Price
- US$14.62 average (US$14.60 to US$15.58)
- Value
- US$117K
- Holding after
- 166,844 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | Option exercise | 4,000 | US$4.30 | 174,844 | Direct |
| May 5, 2026 | Common Stock | Sale | 7,800 | US$14.60 | 167,044 | Direct |
| May 5, 2026 | Common Stock | Sale | 200 | US$15.58 | 166,844 | Direct |
Source
Related
- Cullinan Therapeutics, Inc.
- Michaelson Jennifer
- Cullinan Therapeutics, Inc. shareholders
- Form 4 · Michaelson Jennifer · Sep 10, 2026
- Form 4 · Michaelson Jennifer · Aug 14, 2026
- Form 4 · Michaelson Jennifer · Jul 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Sumer Jacquelyn L · Jul 2, 2026
- Form 4 · Fenton Mary Kay · Jul 2, 2026